Advances in Hematological Malignancies
Recent centuries have witnessed remarkable advancements in the area of hematological malignancies. Novel approaches such as targeted agents, immunotherapies, and therapy are transforming the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering promise for more effective treatment